News Biliary tract cancer drug granted orphan drug designation in... The US regulator has granted biliary tract cancer therapy Silmitasertib orphan drug designation.
News Japan approves Pfizer COVID vaccine for children aged 5 to 1... Japan's health ministry has authorised the use of Pfizer and BioNTech COVID-19 vaccine in children aged between five and 11.
News Covid vaccine booster raises antibody levels in fight agains... A third dose of vaccine has been shown to effectively neutralise the Omicron variant of covid-19, according to researchers.
News UK green lights Gilead Sciences, Galapagos ulcerative coliti... The UK Medicines and Healthcare products Regulatory Agency (MHRA) has approved Jyseleca (filgotinib) 200mg tablets to treat ulcerative colitis (UC) in adults whose UC is moderately to severely acti
News Glenmark and Lotus partner on allergic rhinitis spray The mission to treat people who suffer from allergic rhinitis has been given a boost as two pharma companies join forces.
Partner Content Partner Content 6 critical success factors of a successful rapid first comme... Annemarie Armstrong shares key factors for rapid launch
News Ambrosia's sweet $100m round, and other biofinancings Our latest crop of biofinancings has a nine-figure round for Ambrosia, with Pinnacle Medicines, Immutrin, and Gilgamesh Pharma also raising new funds.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
